The IND Approval From The FDA, Experimental Acromegaly Drug Will Enter Phase 3 Trials
According to a story from Markets Insider, the biopharmaceutical company Camurus has recently issued an announcement indicating that the US Food and Drug Administration (FDA) has accepted the company's Investigational…